Clinical Trial

Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter Study

Name: Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter Study — clinical trial record (NCT07746050)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SEPSYM

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the value of biomarkers of neuronal and glial injury for predicting cognitive impairment (memory impairment assessed by a MoCA score \< 26/30) at 3 months in patient admitted in the intensive care unit for a sepsis or a septic shock.

Trial Details

NCT Number	NCT07746050
Lead Sponsor	Assistance Publique - Hôpitaux de Paris Collaborators: URC-CIC Paris Descartes Necker Cochin, ANR and Ministry of Health
Conditions	Sepsis, Septic Shock
Enrollment	210 participants
Start Date	2026-09
Primary Completion	2028-05 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-08-04